AFT Pharmaceuticals gets greenlight for nine additional European countries

Rebecca Howard
Thu, 18 May 2017

By Rebecca Howard May 19 (BusinessDesk) -  AFT Pharmaceuticals obtained regulatory approval to sell its Maxigesic painkiller in nine additional European countries, a move that lets it ramp up international sales of its tablets.  The Auckland-based drug maker said the European Medicines Agency approved Maxigesic tablets in Austria, Belgium, Croatia, France, Germany, Luxembourg, Netherlands, Portugal and Spain. These countries have been added to the existing European countries where Maxigesic has been approved for sale. "Collectively the...

Use the information you’ve already given Google to create your subscription.

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets
Fonterra caps shareholders' fund – but axe looms
Rebecca Howard | Thu, 06 May 2021

Fonterra chair Peter McBride says "surprise" move to cap the shareholders' fund wasn't taken lightly, but farmer control of the co-op must be protected.

Technology FREE
Te reo Māori included in Google’s new language tool
Henry Burrell | Thu, 06 May 2021

The interactive project aims to encourage the use of ten indigenous global languages. 

Finance
Final bids due in mortgagee sale of Kerr’s Arrowtown property
Paul McBeth | Thu, 06 May 2021

The dispute between George Kerr and BNZ is heating up.

Partner Content
Productivity concerns and signs of stagflation

Inflation is to be expected in New Zealand, and whilst costs and prices rise, output capacity appears constrained, at least in the short-term; raising the possibility of stagflation.

Sponsored
What you do matters - keeping our crowded places safe

FIRST Security's Chief Operating Officer Steve Sullivan looks at how venue operators and event organisers can implement the new government strategy to protect staff and visitors from armed attacks.